Search clinical trials for: site marking

Total 82920 results

Eli Lilly and Company

Completed

Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents

Breast Neoplasms

France, Germany, Italy, Netherlands, Spain, United Kingdom
Skane University Hospital
Swedish Cancer Society; Europe Against Cancer (European Union Directorate General...

Completed

Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening (SWEDESCREEN)

Cervical Cancer | Cervical Intraepithelial Neoplasia

Sweden
Eli Lilly and Company

Completed

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Breast Cancer | Ovarian Cancer | Endometrial Cancer

United States
Shandong University

Completed

Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm (TACE-RFA)

Hepatocellular Carcinoma
Pfizer

Terminated

Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.

Parkinson Disease

Australia, Italy, Spain
Eli Lilly and Company

Completed

Effects of Teriparatide in Postmenopausal Women With Osteoporosis

Postmenopausal Osteoporosis

United States
Eli Lilly and Company

Completed

Duloxetine vs. Active Comparator in the Treatment of Patients With Depression

Depression

France
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine vs Placebo in the Treatment of General Anxiety

Anxiety

United States
Eli Lilly and Company

Completed

Study of Duloxetine in Elderly Patients With Major Depressive Disorder

Depression | Cognition

United States
Eli Lilly and Company

Completed

Urge Incontinence Bladder Overactivity Study

Urinary Incontinence

United States, Australia, Canada
Eli Lilly and Company

Completed

Efficacy and Safety Stress Urinary Incontinence Study

Urinary Incontinence, Stress

Taiwan
Eli Lilly and Company

Completed

Duloxetine Stress Urinary Incontinence Efficacy and Safety Study

Urinary Incontinence, Stress

Korea, Republic of
Eli Lilly and Company

Completed

Duloxetine vs. Active Comparator for the Treatment of Depression

Depression

Canada
Finnish Breast Cancer Group
Sanofi; Hoffmann-La Roche; AstraZeneca

Completed

Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer

Breast Cancer

Finland
Eli Lilly and Company

Completed

A Study for the Treatment of Painful Diabetic Neuropathy

Diabetic Neuropathy, Painful

United States
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Unknown

A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer

Pancreatic Cancer

Taiwan
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study of Duloxetine in the Treatment of Fibromyalgia

Fibromyalgia

Argentina, Australia, Brazil, Canada, Mexico, Poland, Taiwan
Eli Lilly and Company

Completed

Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy

Ovarian Neoplasms | Primary Peritoneal Cancer

Spain, Germany, Belgium, United Kingdom
Eli Lilly and Company

Completed

A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer

Superficial Bladder Cancer

Israel
University Hospital, Geneva

Unknown

Intravascular Ultrasound for Hepatocellular Carcinoma Staging

Hepatocellular Carcinoma

Switzerland
Hadassah Medical Organization

Unknown

Radiation Induced Atherosclerosis in Breast Cancer Patients

Breast Cancer | Atherosclerosis | Abnormalities, Radiation-Induced

Israel
Eli Lilly and Company

Completed

Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

Vasomotor Symptoms | Endometrial Safety

United States
Eli Lilly and Company

Completed

Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

Canada, United States
Pharmacyclics LLC.

Completed

Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors

Breast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Ovarian Neoplasms

United States
Eli Lilly and Company

Completed

A Study in People With Mild Hypertension

Mild Hypertension

Sweden
Pfizer
Diabetes UK; Department of Health, United Kingdom

Completed

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events (CARDS)

Angina, Unstable | Cerebrovascular Accident | Coronary Artery Bypass Graft | Revascularization | Major Coronary Event

United Kingdom
Chinese University of Hong Kong

Terminated

Method of Exit Site Care in Chronic Peritoneal Dialysis Patients

Chronic Peritoneal Dialysis

Hong Kong
Pharmacyclics LLC.

Terminated

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Head and Neck Cancer | Oropharynx Cancer | Larynx Cancer | Hypopharynx Cancer

United States
Seattle Cancer Treatment and Wellness Center

Unknown

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

Stage III Pancreatic Cancer | Stage IVA Pancreatic Cancer | Stage IVB Pancreatic Cancer | Adenocarincoma of Pancreas

United States
Tampere University

Completed

Casodex/Zoladex Biomarkers in Localised Prostate Cancer

Prostate Cancer

Finland
Pharmacyclics LLC.

Completed

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Carcinoma, Non-Small-Cell Lung | Brain Neoplasms | Metastases, Neoplasm

United States, France, Belgium, Germany, Canada, Netherlands, Austria, Australia
Pfizer

Completed

Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)

Macular Degeneration

Japan
Johann Wolfgang Goethe University Hospital
Bethanien Krankenhaus gGmbH

Completed

Role of Prophylactic Antibiotics in New Introducer PEG-Gastropexy

Head and Neck Neoplasms | Wound Infection

Germany
Novacea
Aventis Pharmaceuticals

Completed

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Pfizer

Completed

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

Kidney Neoplasms

United States
Pfizer

Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Hodgkin Disease | Thrombocytopenia | Non-Hodgkin Lymphoma

United States, Russian Federation, Singapore, Australia, France, Hong Kong, Greece, Poland
Pfizer

Completed

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic Neoplasms

United States
Tel-Aviv Sourasky Medical Center
Rabin Medical Center; Kaplan Medical Center

Unknown

Evaluation of NiTi Shape Memory End-to-End Compression Anastomosis Ring (CAR) for Compression Anastomosis in Anterior Resection

Colorectal Cancer

Israel
Pfizer

Completed

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Breast Neoplasms

United States, Canada, Ireland, Italy, Sweden, Belgium, France, Spain, United Kingdom
Novartis

Completed

Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold

Common Cold

United Kingdom
Pfizer

Completed

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels (TNT)

Cardiovascular Disease | Coronary Heart Disease | Cerebrovascular Accident

United States, Australia, Netherlands, Canada, Spain, France, Austria, Italy, South Africa, Belgium, Germany, Switzerland, Ireland, United Kingdom
University of Alberta, Physical Education

Completed

Physical Activity Promotion in Breast Cancer Survivors

Breast Cancer

Canada
Eli Lilly and Company

Completed

Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.

Non-Small-Cell Lung Carcinoma

United States
Tehran University of Medical Sciences

Completed

Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients

Laryngeal Cancer

Iran, Islamic Republic of
Pfizer

Completed

Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women

Hypertension | Menopause

Hungary
Radboud University Medical Center

Completed

The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer Patients

Head and Neck Neoplasms

Netherlands
Ontario Clinical Oncology Group (OCOG)
Pfizer

Completed

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Venous Thromboembolism | Brain Tumors

United States, Canada, Australia, Italy
Grupo Gallego de Cancer de Pulmon

Unknown

Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Spain
New York Presbyterian Hospital

Completed

Randomized Controlled Trial Comparing Different Closure Methods for Laparoscopic Port Sites

Laparoscopic Cosmesis
Henry Ford Health System
Birch Point Medical

Completed

Randomized Trial of Iontophoresis Versus Injection of Corticosteroids for Lateral Epicondylitis

Lateral Epicondylitis | Work Related Injury

United States

Search clinical trials for: site marking

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations